Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02097303
What this trial is testing

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Who this might be right for
Prostate Cancer
Carolina Research Professionals, LLC 36
Early research (Phase 1)Ended earlyNCT04279561
What this trial is testing

Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more
Jonsson Comprehensive Cancer Center 9
Early research (Phase 1)Looking for participantsNCT07316686
What this trial is testing

Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Instituto do Cancer do Estado de São Paulo 18
Testing effectiveness (Phase 2)Study completedNCT05081193
What this trial is testing

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Ended earlyNCT02985021
What this trial is testing

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
Seattle Institute for Biomedical and Clinical Research 2
Early research (Phase 1)Looking for participantsNCT07660211
What this trial is testing

Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC）

Who this might be right for
PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VitsGen Therapeutics Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT05588609
What this trial is testing

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Who this might be right for
NSCLC Harboring NRG1 FusionMetastatic Castration-resistant Prostate Cancer
Partner Therapeutics, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT01666314
What this trial is testing

Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 137
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)UnknownNCT01949337
What this trial is testing

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Alliance for Clinical Trials in Oncology 1,311
Testing effectiveness (Phase 2)UnknownNCT03356912
What this trial is testing

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Consorzio Oncotech 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT03230734
What this trial is testing

Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Not applicableNot Yet RecruitingNCT07674121
What this trial is testing

PROLONG (PRostateOLaparibONcombinationGcc) Study

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
AstraZeneca 75
Early research (Phase 1)UnknownNCT05607693
What this trial is testing

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Who this might be right for
Castration-Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT03503344
What this trial is testing

Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaPSA Progression+1 more
University of California, San Francisco 26
Early research (Phase 1)UnknownNCT02631616
What this trial is testing

Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET

Who this might be right for
Prostatic Neoplasms
Hadassah Medical Organization 30
Large-scale testing (Phase 3)Study completedNCT00974311
What this trial is testing

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

Who this might be right for
Castration-Resistant Prostate Cancer
Pfizer 1,199
Testing effectiveness (Phase 2)Study completedNCT04381832
What this trial is testing

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantAndrogen-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms+1 more
Arcus Biosciences, Inc. 173
Testing effectiveness (Phase 2)Study completedNCT01541007
What this trial is testing

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jeffrey Yachnin M.D., PhD. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471974
What this trial is testing

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaMetastatic Prostate Small Cell Carcinoma+3 more
Rahul Aggarwal 61
Next Page